{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_017638.3:c.425G>A",
          "cDNA Change": {
            "transcript": "NM_017638.3",
            "ref": "G",
            "alt": "A",
            "position": "425"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "H",
            "position": "142"
          },
          "Description in input context": "R1441G"
        },
        {
          "HGVS": "NM_017638.3:c.5089T>C",
          "cDNA Change": {
            "transcript": "NM_017638.3",
            "ref": "T",
            "alt": "C",
            "position": "5089"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "H",
            "position": "1697"
          },
          "Description in input context": "Y1699C"
        },
        {
          "HGVS": "NM_017638.3:c.5102G>A",
          "cDNA Change": {
            "transcript": "NM_017638.3",
            "ref": "G",
            "alt": "A",
            "position": "5102"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "1701"
          },
          "Description in input context": "G2019S"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005022"
  },
  "Experiment Method": [
    {
      "Assay Method": "Affinity purification and mass spectrometric analysis",
      "Material used": {
        "Material Source": "Mouse brain tissue",
        "Material Name": "Mouse brain",
        "Description": "Phosphorylation sites and binding affinity were analyzed using mouse brain tissue."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017638.3:c.425G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation and altered 14-3-3 binding",
          "Result Description": "R1441G mutation reduced phosphorylation levels at S935 and disrupted 14-3-3 binding."
        },
        {
          "Variant": "NM_017638.3:c.5089T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation and altered 14-3-3 binding",
          "Result Description": "Y1699C mutation reduced phosphorylation levels at S935 and disrupted 14-3-3 binding."
        },
        {
          "Variant": "NM_017638.3:c.5102G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation and altered 14-3-3 binding",
          "Result Description": "G2019S mutation reduced phosphorylation levels at S935 and disrupted 14-3-3 binding."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated across multiple mouse brains and ages."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control for phosphorylation and binding assays."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or non-phosphorylatable LRRK2 variants were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels > 80% of wild-type",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels < 50% of wild-type",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell culture and kinase assays",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells",
        "Description": "Cell culture experiments were performed to test the effect of PKA on phosphorylation."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017638.3:c.425G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation",
          "Result Description": "R1441G mutation showed reduced phosphorylation in response to PKA activation."
        },
        {
          "Variant": "NM_017638.3:c.5089T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation",
          "Result Description": "Y1699C mutation showed reduced phosphorylation in response to PKA activation."
        },
        {
          "Variant": "NM_017638.3:c.5102G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation",
          "Result Description": "G2019S mutation showed reduced phosphorylation in response to PKA activation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control for phosphorylation assays."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-phosphorylatable LRRK2 variants were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels > 80% of wild-type",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels < 50% of wild-type",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}